These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 9007653)

  • 41. A cost-based decision analysis for Chlamydia screening in California family planning clinics.
    Trachtenberg AI; Washington AE; Halldorson S
    Obstet Gynecol; 1988 Jan; 71(1):101-8. PubMed ID: 3122137
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Predictors of Chlamydia trachomatis infection among female adolescents: a longitudinal analysis.
    Mosure DJ; Berman S; Kleinbaum D; Halloran ME
    Am J Epidemiol; 1996 Nov; 144(10):997-1003. PubMed ID: 8916511
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Chlamydia trachomatis infection among Hispanic women in the California-Mexico border area, 1993: establishing screening criteria in a primary care setting.
    Gunn RA; Hillis SD; Shirey P; Waterman SH; Greenspan JR
    Sex Transm Dis; 1995; 22(6):329-34. PubMed ID: 8578402
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Widespread screening seeks to lower Chlamydia prevalence.
    Donovan P
    Fam Plann Perspect; 1992; 24(3):135-6. PubMed ID: 1628717
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Chlamydia trachomatis infection in women: a need for universal screening in high prevalence populations?
    Weinstock HS; Bolan GA; Kohn R; Balladares C; Back A; Oliva G
    Am J Epidemiol; 1992 Jan; 135(1):41-7. PubMed ID: 1736659
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Incident Chlamydia trachomatis infections among inner-city adolescent females.
    Burstein GR; Gaydos CA; Diener-West M; Howell MR; Zenilman JM; Quinn TC
    JAMA; 1998 Aug; 280(6):521-6. PubMed ID: 9707141
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Adolescents and chlamydia: cervix microbiology among adolescents; the first statistics of the family planning centers according to the Calmat law].
    Henry-Suchet J
    Contracept Fertil Sex; 1995 May; 23(5):323-6. PubMed ID: 7613578
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Cost-benefit analysis of selective screening criteria for Chlamydia trachomatis infection in women attending Colorado family planning clinics.
    Humphreys JT; Henneberry JF; Rickard RS; Beebe JL
    Sex Transm Dis; 1992; 19(1):47-53. PubMed ID: 1561588
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Selective screening for chlamydial infection: which criteria to use?
    Miller WC; Hoffman IF; Owen-O'Dowd J; McPherson JT; Privette A; Schmitz JL; Woodlief G; Leone PA
    Am J Prev Med; 2000 Feb; 18(2):115-22. PubMed ID: 10698241
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Re-evaluating selective screening criteria for chlamydial infection among women in the U S Pacific Northwest.
    La Montagne DS; Patrick LE; Fine DN; Marrazzo JM;
    Sex Transm Dis; 2004 May; 31(5):283-9. PubMed ID: 15107630
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Decreased prevalence of Chlamydia trachomatis infection associated with a selective screening program in family planning clinics in Wisconsin.
    Addiss DG; Vaughn ML; Ludka D; Pfister J; Davis JP
    Sex Transm Dis; 1993; 20(1):28-35. PubMed ID: 8430355
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Chlamydia trachomatis screening in family planning centers: a review of cost/benefit evaluations in different countries.
    Henry-Suchet J; Sluzhinska A; Serfaty D
    Eur J Contracept Reprod Health Care; 1996 Dec; 1(4):301-9. PubMed ID: 9678112
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Criteria for selective screening for Chlamydia trachomatis.
    Paukku M; Kilpikari R; Puolakkainen M; Oksanen H; Apter D; Paavonen J
    Sex Transm Dis; 2003 Feb; 30(2):120-3. PubMed ID: 12567168
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Performance and cost-effectiveness of selective screening criteria for Chlamydia trachomatis infection in women. Implications for a national Chlamydia control strategy.
    Marrazzo JM; Celum CL; Hillis SD; Fine D; DeLisle S; Handsfield HH
    Sex Transm Dis; 1997 Mar; 24(3):131-41. PubMed ID: 9132979
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Efforts by commercial health plans to increase Chlamydia trachomatis screening among their members.
    Atherly A; Blake SC
    Sex Transm Dis; 2013 Jan; 40(1):55-60. PubMed ID: 23254117
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Expanding efforts to prevent chlamydial infection.
    Stamm WE
    N Engl J Med; 1998 Sep; 339(11):768-70. PubMed ID: 9731096
    [No Abstract]   [Full Text] [Related]  

  • 57. Predictors of Chlamydia trachomatis infection among women attending rural Midwest family planning clinics.
    Hilger TM; Smith EM; Ault K
    Infect Dis Obstet Gynecol; 2001; 9(1):3-8. PubMed ID: 11368256
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Chlamydia trachomatis screening in family planning clinics in Wisconsin.
    Katcher ML; Addiss DG; Vaughn ML
    Wis Med J; 1986 Jan; 85(1):27. PubMed ID: 3754078
    [No Abstract]   [Full Text] [Related]  

  • 59. Chlamydia trachomatis.
    McSherry J
    Br J Gen Pract; 1995 Apr; 45(393):219-20. PubMed ID: 7612331
    [No Abstract]   [Full Text] [Related]  

  • 60. Estimating chlamydia re-infection rates: an empirical example.
    Torrone EA; Satterwhite CL; Scholes D; Yu O; Berman S; Peterman TA
    Sex Transm Infect; 2013 Aug; 89(5):388-90. PubMed ID: 23644175
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.